Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of active pharmaceutical ingredients (APIs) where the morpholine ring serves as a structural scaffold. The Boc group protects the nitrogen atom of the morpholine, allowing for selective deprotection, while the unprotected hydroxymethyl group enables further functionalization, making it valuable in multi-step organic synthesis. Commonly employed in medicinal chemistry for constructing kinase inhibitors, CNS agents, and other bioactive molecules. Its polarity and hydrogen-bonding capability also make it useful in improving solubility and pharmacokinetic properties of drug candidates.